Ketazed

Ketotifen hydrogen fumarate, the active ingredient in Ketazed, is an antihistamine (mast cell stabilizer) presented as an ophthalmic solution for ocular use. It is employed to treat allergic conjunctivitis and seasonal allergic eye disease in patients experiencing ocular allergy symptoms.

GNH USA supplies Ketazed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the supply chain.

Ketazed is used to manage ocular allergic conditions by reducing histamine‑mediated inflammation.

- Allergic conjunctivitis: alleviates redness, itching and tearing associated with eye allergy. - Seasonal allergic eye disease: controls symptoms triggered by pollen or seasonal allergens. - Vernal keratoconjunctivitis: helps reduce chronic inflammation and photophobia in affected patients.

Ketazed may cause ocular and systemic adverse reactions, which are generally mild and transient.

Common Side Effects: - Burning sensation: transient stinging upon instillation. - Blurred vision: temporary reduction in visual acuity. - Redness: conjunctival hyperemia after dosing. - Dry eye: decreased tear production causing discomfort. - Tearing: increased lacrimation in the treated eye. - Headache: mild systemic headache reported by some users.

Serious or Rare Side Effects: - Corneal ulceration: persistent pain and visual loss requiring urgent care. - Severe allergic reaction: swelling, rash, or anaphylaxis. - Vision loss: sudden decrease in sight needing immediate evaluation.

When using Ketazed, certain precautions should be observed to ensure safety and optimal therapeutic effect. - Hypersensitivity: avoid use in patients with known allergy to ketotifen or formulation components. - Contact lens wear: discontinue lenses during treatment and resume only after thorough rinsing. - Ocular infection: monitor for signs of infection and discontinue if infection develops. - Glaucoma: use with caution in patients with narrow‑angle glaucoma, as intra‑ocular pressure changes may occur. - Systemic antihistamines: be aware of additive sedative effects if combined with systemic antihistamines. - Store at room temperature: keep in original container, protect from light and moisture.

Ketazed can interact with other medications; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of ocular hypertension. - Other mast cell stabilizers: combined therapy can lead to excessive ocular irritation. - MAO inhibitors: may potentiate systemic antihistaminic effects.

Moderate Interactions (Monitor Closely): - Oral antihistamines: may enhance systemic antihistaminic effects, causing drowsiness. - Beta‑blocker eye drops: potential additive reduction in intra‑ocular pressure. - Non‑steroidal anti‑inflammatory eye drops: increased risk of corneal epithelial toxicity. - Contact lens solutions containing preservatives: may exacerbate ocular irritation. - Cyclosporine ophthalmic solution: may alter tear film stability, monitor comfort.